Suppression of tumor necrosis factor-α-induced nuclear factor κb activation and aromatase activity by capsaicin and its analog capsazepine

Journal of Medicinal Food

Volumn 14, Issue 11, 2011, Pages 1344-1351

  Luqman, Suaib ^a   Meena, Abha ^a   Marler, Laura E ^b   Kondratyuk, Tamara P ^b   Pezzuto, John M ^b  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

cancer chemoprevention; capsaicin; molecular docking; nociceptors; nuclear factor j light chainenhancer of activated B cells; red pepper; tumor necrosis factor a; vanilloids

Indexed keywords

AROMATASE; CAPSAICIN; CAPSAZEPINE; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOLEUCINE; NARINGENIN; NF KAPPA B P100 SUBUNIT; SERINE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALINE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG MECHANISM; DRUG STRUCTURE; EMBRYO CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROGEN BOND; IC 50; KIDNEY CELL; MOLECULAR DOCKING; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; AROMATASE; CAPSAICIN; CAPSICUM; CELL LINE; HUMANS; INHIBITORY CONCENTRATION 50; NF-KAPPA B; PLANT EXTRACTS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

CAPSICUM ANNUUM; CAPSICUM ANNUUM VAR. ANNUUM;

EID: 80755125243     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0236     Document Type: Article

References (54)

1. Jansco G, Kiraly E, Jansco-Gabor A: Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 1977;270:741-743. (Pubitemid 8239254)
2. Szallasi PM, Blumberg PM: Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-211. (Pubitemid 29269981)
3. Szallasi PM, Blumberg PM: Vanilloid receptor: new insights enhance potential as a therapeutic target. Pain 1996;68:195-208. (Pubitemid 27025876)
4. Macho A, Calzado MA, Muñoz-Blanco J, et al.: Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ 1999;6:155-165. (Pubitemid 29082304)
5. Uchida M, Yano S, Watanabe K: The role of capsaicin sensitive afferent nerves in protective effect of capsaicin against absolute ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1991;55: 279-282.
6. Cichewicz RH, Thorpe PA: The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. J Ethnopharmacol 1996;52:61-70. (Pubitemid 26137612)
7. Franco-Cereceda A, Lundberg JM: Actions of calcitonin generelated peptide and tachykinins in relation to the contractile effects of capsaicin in the guinea-pig and rat heart in vitro. Naunyn Schmiedebergs Arch Pharmacol 1988;337:649-655.
8. Srinivasan MR, Satyanarayana MN: Effect of capsaicin on lipoprotein lipase in rats fed high fat diet. Indian J Exp Biol 1989; 27:910-912. (Pubitemid 19251693)
9. Rizvi SI, Luqman S: Capsaicin-induced activation of erythrocyte membrane acetyl cholinesterase activity. Med Chem Res 2001; 10:502-506. (Pubitemid 34074710)
10. Rizvi SI, Luqman S: Anti-oxidative property of capsaicin. Med Chem Res 2002;11:301-307. (Pubitemid 36152933)
11. Rizvi SI, Luqman S: Capsaicin-induced changes in erythrocyte membrane adenosine triphosphatases activity. Cell Mol Biol Lett 2003;8:919-926.
12. Luqman S, Rizvi SI: Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress. Phytother Res 2006;20:303-306.
13. Rizvi SI, Luqman S: Capsicum: a medically important spice. In: Spices: The Elixir of Life. (De AK, ed.). Originals, New Delhi, 2011, pp. 77-86.
14. Materska M, Perucka I: Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L). J Agric Food Chem 2005;53:1750-1756. (Pubitemid 40326270)
15. Kempalah RK, Srinivasan K: Influence of dietary curcumin, capsaicin and garlic on the antioxidant status of red blood cells and the liver in high-fat-fed rats. Ann Nutr Metab 2004;48:314-320. (Pubitemid 39656682)
16. Melisi D, Chiao PJ: NFjB as a target for cancer therapy. Expert Opin Ther Targets 2007;11:133-144.
17. Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397-1421.
18. Chen F, Castranova V, Shi X: New insights into the role of nuclear factor jB in cell growth regulation. Am J Pathol 2001;159:387-397. (Pubitemid 32751067)
19. Thanos D, Maniatis T: NFjB: a lesson in family values. Cell 1995;80:529-532.
20. Luqman S, Pezzuto JM: NFjB: a promising target for natural products in cancer chemoprevention. Phytother Res 2010;24: 949-963.
21. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NFjB. J Clin Invest 2001;107:241-246. (Pubitemid 32157954)
22. Inoue J, Gohda J, Akiyama T, Semba K: NFjB activation in development and progression of cancer. Cancer Sci 2007;98:268-274. (Pubitemid 46195594)
23. Frydrych I, Mlejnek P: Serine protease inhibitors N-tosyl-l-lysinyl- chloromethylketone (TLCK) and N-tosyl-l-phenylalaninylchloromethylketone (TPCK) are potent inhibitors of activated caspase proteases. J Cell Biochem 2008;103:1646-1656. (Pubitemid 351490729)
24. Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NFjB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142. (Pubitemid 32096826)
25. Mamett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992;52:5575-5589.
26. Czajka-Oraniec I, Simpson ER: Aromatase research and its clinical significance. Endokrynol Pol 2010;61:126-134.
27. Balunas MJ, Kinghorn AD: Natural compounds with aromatase inhibitory activity: an update. Planta Med 2010;76:1087-1093.
28. Fabian CJ, Kimler BF, Mayo MS, Grizzle WE, Masood S, Ursin G: Clinical approaches to discovering and testing new breast cancer prevention drugs. In: Cancer Chemoprevention, Vol. 2 (Kelloff GJ, Hawk ET, Sigman CC, eds.). Humana Press, Totowa, NJ, 2005, pp. 213-237.
29. Maiti A, Cuendet M, Croy VL, Endringer DC, Pezzuto JM, Cushman M: Synthesis and biological evaluation of ( - )-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer. J Med Chem 2007;50:2799-2806. (Pubitemid 46980851)
30. Strasser-Weippl K, Goss PE: Counteracting estrogen as breast cancer prevention. In: Cancer Chemoprevention, Vol. 2 (Kelloff GJ, Hawk ET, Sigman CC, eds.). Humana Press, Totowa, NJ, 2005, pp. 249-264.
31. Recanatini M, Cavalli A, Valenti P: Nonsteroidal aromatase inhibitors: recent advances. Med Res Rev 2002;22:282-304. (Pubitemid 34415467)
32. Morais MCC, Luqman S, Kondratyuk TP, et al.: Suppression of TNF-a induced NFjB activity by gallic acid and its semisynthetic alkyl-gallates: possible role in cancer chemoprevention. Nat Prod Res 2010;20:1-8.
33. Homhual S, Zhang HJ, Bunyapraphatsara N, et al.: Bruguiesulfurol, a new sulfur compound from Bruguiera gymnorrhiza. Planta Med 2006;72:255-260.
34. Skehan P, Storeng R, Scudiero D, et al.: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-1112. (Pubitemid 20213250)
35. Lipinski CA: Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-249. (Pubitemid 32239479)
36. Rumsfield JA, West DP: Topical capsaicin in dermatologic and peripheral pain disorder. DICP 1991;25:381-387.
37. Surh YJ: Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic compounds. Mutat Res 1999;428:305-327.
38. Luqman S, Rizvi SI: Activation of erythrocyte plasma membrane redox system by capsaicin: a possible mechanism to explain its antioxidative effect. Oxid Commun 2010;33:430-435.
39. Morre DJ, Chueh PJ, Morre DM: Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in cultures. Proc Natl Acad Sci U S A 1995;92:1831-1835.
40. Wolvetang EM, Larm JA, Moutsoulas P, Lawen A: Apoptosis induced by inhibitors of the plasma membrane NADH oxidase involves Bcl-2 and calceneurin. Cell Growth Differ 1996;7: 1315-1325. (Pubitemid 26360680)
41. Buck SH, Burks SH: The neuropharmacology of capsaicin-review of some recent observations. Pharmacol Rev 1986;38:179-226. (Pubitemid 16031645)
42. Meddings JB, Hogaboam CM, Tran K, Reynolds JD, Wallace JL: Capsaicin effects on non-neuronal plasma membranes. Biochim Biophys Acta 1991;1070:43-50.
43. Aranda FJ, Villalain J, Fernandez-Gomez JC: Capsaicin affects the structure and phase organization of phospholipid membranes. Biochim Biophys Acta 1995;1234:225-234.
44. Tsuchiya H: Biphasic membrane effects of capsaicin, an active component in Capsicum sp. J Ethnopharmacol 2001;75:295-299. (Pubitemid 32297749)
45. Kopp E, Ghosh S: Inhibition of NFjB by sodium salicylate and aspirin. Science 1994;265:956-959.
46. Singh S, Aggarwal BB: Activation of transcription factor NFjB is suppressed by curcumin (diferulolylmethane). J Biol Chem 1996;270:24995-25000.
47. Gerritsen ME, Carley WW, Ranges GE, et al.: Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995;147:278-292.
48. Mellitis KH, Hay RT, Goodbourn S: Proteolytic degradation of MAD3 (IjBa) and enhanced processing of the NFjB precursor p105 are obligatory steps in the activation of NFjB. Nucleic Acids Res 1993;21:5059-5066. (Pubitemid 23342513)
49. Kirillova I, Chaisson M, Fausto N: Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor jB activation. Cell Growth Differ 1999;10:819-828. (Pubitemid 30036254)
50. Oyagbemi AA, Saba AB, Azeez OI: Capsaicin: a novel chemopreventive molecule and its underlying molecular mechanisms of action. Indian J Cancer 2010;47:53-58.
51. Surh YJ, Han SS, Keum YS, Seo HJ, Lee SS: Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kappaB and AP-1. Biofactors 2000;12:107-112.
52. Han SS, Keum YS, Seo HJ, Surh YJ: Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 2002;35:337-342.
53. Oh GS, Pae HO, Seo WG, et al.: Capsazepine, a vanilloid receptor antagonist, inhibits the expression of inducible nitric oxide synthase gene in lipopolysaccharide-stimulated RAW264.7 macrophages through the inactivation of nuclear transcription factor-kappa B. Int Immunopharmacol 2001;1:777-784.
54. Kim CS, Kawada T, Kim BS, et al.: Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal 2003;15: 299-306. (Pubitemid 36071674)